Company

Chronic kidney diseases are a severe and growing worldwide health challenge that affects 1 in 7 people. Without effective treatments patients can experience kidney failure leading to dialysis and transplantation, a high burden to patients, families and the health care system. Despite recent advances for certain kidney disease patients, many forms of highly prevalent kidney diseases do not have effective treatments.

Position

The Biomarker & Bioanalytical Development Lead is Borealis' senior scientific owner of bioanalytical and biomarker strategy across our RNA therapeutics portfolio. This leader will design, build, and oversee the assays that measure drug exposure, target engagement, pharmacodynamic response, and safety in support of IND-enabling nonclinical and early clinical development. This is a highly visible, hands-on scientific leadership role with the prospect to shape how Borealis generates the translational data that drives program decisions.

The immediate focus for this role is preparing Borealis for its upcoming Phase 1/2 trial, including development,

📌 Biomarker & Bioanalytical Development Lead (Director / Senior Director) (Vancouver)
🏢 Borealis Biosciences
📍 Vancouver